Protalix Biotherapeutics
Price & Volume
Stats
See more52W Range | $0.89-$3.10 |
Market Cap | $121M |
Shares Short | 3M |
Financials
See moreRevenue (12 Mos) | $59.7M |
Revenue Growth (YoY) | 169.8% |
Gross Profit (12 Mos) | $29.8M |
Diluted EPS | $0.05 |
News
See moreYahoo Finance • 25 days ago
Protalix BioTherapeutics appoints Gilad Mamlok as CFO
Yahoo Finance • last month
Earnings call transcript: Pluxee NV Q3 2025 sees stock rise despite revenue miss
Yahoo Finance • last month
Pluxee Q3 Fiscal 2025 slides: Double-digit revenue growth continues, objectives reaffirmed
Yahoo Finance • last month
Pluxee posts 11.1% organic revenue growth in Q3 on solid volumes
About
CEO | Mr. Dror Bashan |
CFO | Mr. Eyal Rubin M.B.A. |
Address | 2 University Plaza, Hackensack, NJ, United States, 07601 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 213 |
